Published in Science on May 24, 1991
Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation. Proc Natl Acad Sci U S A (1997) 4.03
A unified genetic theory for sporadic and inherited autism. Proc Natl Acad Sci U S A (2007) 3.47
Prevalence of carriers of premutation-size alleles of the FMRI gene--and implications for the population genetics of the fragile X syndrome. Am J Hum Genet (1995) 2.77
The fragile X syndrome d(CGG)n nucleotide repeats form a stable tetrahelical structure. Proc Natl Acad Sci U S A (1994) 2.72
Size of the unstable CTG repeat sequence in relation to phenotype and parental transmission in myotonic dystrophy. Am J Hum Genet (1993) 2.42
Screening and diagnosis for the fragile X syndrome among the mentally retarded: an epidemiological and psychological survey. Collaborative Fragile X Study Group. Am J Hum Genet (1997) 2.27
Characterization of dFMR1, a Drosophila melanogaster homolog of the fragile X mental retardation protein. Mol Cell Biol (2000) 2.18
Simple tandem DNA repeats and human genetic disease. Proc Natl Acad Sci U S A (1995) 2.18
The fragile X mental retardation syndrome protein interacts with novel homologs FXR1 and FXR2. EMBO J (1995) 2.05
Regional FMRP deficits and large repeat expansions into the full mutation range in a new Fragile X premutation mouse model. Gene (2007) 2.01
The fragile X syndrome. J Med Genet (1998) 2.00
Quantitative comparison of FMR1 gene expression in normal and premutation alleles. Am J Hum Genet (1995) 1.91
Fragile-X carrier screening and the prevalence of premutation and full-mutation carriers in Israel. Am J Hum Genet (2001) 1.85
Fragile-X syndrome: unique genetics of the heritable unstable element. Am J Hum Genet (1992) 1.85
A multicenter study on genotype-phenotype correlations in the fragile X syndrome, using direct diagnosis with probe StB12.3: the first 2,253 cases. Am J Hum Genet (1994) 1.84
Advances in understanding the molecular basis of FXTAS. Hum Mol Genet (2010) 1.83
A microdeletion of less than 250 kb, including the proximal part of the FMR-I gene and the fragile-X site, in a male with the clinical phenotype of fragile-X syndrome. Am J Hum Genet (1992) 1.73
Gonosomal mosaicism in myotonic dystrophy patients: involvement of mitotic events in (CTG)n repeat variation and selection against extreme expansion in sperm. Am J Hum Genet (1994) 1.71
Analysis of a CGG sequence at the FMR-1 locus in fragile X families and in the general population. Am J Hum Genet (1993) 1.71
CGG repeat in the FMR1 gene: size matters. Clin Genet (2011) 1.68
Clinical and molecular studies in fragile X patients with a Prader-Willi-like phenotype. J Med Genet (1993) 1.68
Fragile X gene instability: anchoring AGGs and linked microsatellites. Am J Hum Genet (1995) 1.61
FXR1, an autosomal homolog of the fragile X mental retardation gene. EMBO J (1995) 1.61
Mental status of females with an FMR1 gene full mutation. Am J Hum Genet (1996) 1.57
A nuclear role for the Fragile X mental retardation protein. EMBO J (1996) 1.54
FMR1 fully expanded mutation with minimal methylation in a high functioning fragile X male. J Med Genet (1996) 1.54
Triplet repeat expansion at the FRAXE locus and X-linked mild mental handicap. Am J Hum Genet (1994) 1.51
FRAXA and FRAXE: the results of a five year survey. J Med Genet (2000) 1.50
Fragile X and X-linked intellectual disability: four decades of discovery. Am J Hum Genet (2012) 1.50
Neurodegeneration the RNA way. Prog Neurobiol (2011) 1.43
Altered mTOR signaling and enhanced CYFIP2 expression levels in subjects with fragile X syndrome. Genes Brain Behav (2012) 1.41
Autism: the point of view from fragile X studies. J Autism Dev Disord (1998) 1.36
Co-occurring diagnoses among FMR1 premutation allele carriers. Clin Genet (2010) 1.33
Methylation of novel markers of fragile X alleles is inversely correlated with FMRP expression and FMR1 activation ratio. Hum Mol Genet (2010) 1.31
Stability of the human fragile X (CGG)(n) triplet repeat array in Saccharomyces cerevisiae deficient in aspects of DNA metabolism. Mol Cell Biol (1999) 1.24
Dynamic mutation in Dutch Huntington's disease patients: increased paternal repeat instability extending to within the normal size range. J Med Genet (1993) 1.20
Fragile X AGG analysis provides new risk predictions for 45-69 repeat alleles. Am J Med Genet A (2013) 1.19
Genotype-phenotype relationships in fragile X syndrome: a family study. Am J Hum Genet (1993) 1.18
SIRT1 inhibition alleviates gene silencing in Fragile X mental retardation syndrome. PLoS Genet (2008) 1.16
Fragile X syndrome is less common than previously estimated. J Med Genet (1997) 1.15
Fragile X-associated disorders: a clinical overview. J Neurol (2011) 1.13
Young adult female fragile X premutation carriers show age- and genetically-modulated cognitive impairments. Brain Cogn (2011) 1.12
Segregation of FRAXE in a large family: clinical, psychometric, cytogenetic, and molecular data. Am J Hum Genet (1994) 1.11
Variable FMR1 gene methylation of large expansions leads to variable phenotype in three males from one fragile X family. J Med Genet (1996) 1.10
Two new cases of FMR1 deletion associated with mental impairment. Am J Hum Genet (1995) 1.08
The tetraplex (CGG)n destabilizing proteins hnRNP A2 and CBF-A enhance the in vivo translation of fragile X premutation mRNA. Nucleic Acids Res (2007) 1.08
Cloned human FMR1 trinucleotide repeats exhibit a length- and orientation-dependent instability suggestive of in vivo lagging strand secondary structure. Nucleic Acids Res (1998) 1.05
The distribution of repressive histone modifications on silenced FMR1 alleles provides clues to the mechanism of gene silencing in fragile X syndrome. Hum Mol Genet (2010) 1.04
Is there evidence for neuropsychological and neurobehavioral phenotypes among adults without FXTAS who carry the FMR1 premutation? A review of current literature. Genet Med (2009) 1.04
Genome-wide alteration of 5-hydroxymethylcytosine in a mouse model of fragile X-associated tremor/ataxia syndrome. Hum Mol Genet (2013) 1.03
Fragile X syndrome and the (CGG)n mutation: two families with discordant MZ twins. Am J Hum Genet (1994) 1.02
Characterization of a deletion at Xq27-q28 associated with unbalanced inactivation of the nonmutant X chromosome. Am J Hum Genet (1992) 1.02
An atypical case of fragile X syndrome caused by a deletion that includes the FMR1 gene. Am J Hum Genet (1995) 0.98
The role of AGG interruptions in the transcription of FMR1 premutation alleles. PLoS One (2011) 0.97
Repeat instability during DNA repair: Insights from model systems. Crit Rev Biochem Mol Biol (2015) 0.97
Fragile X syndrome: a preclinical review on metabotropic glutamate receptor 5 (mGluR5) antagonists and drug development. Psychopharmacology (Berl) (2014) 0.95
Demethylation, reactivation, and destabilization of human fragile X full-mutation alleles in mouse embryocarcinoma cells. Am J Hum Genet (2001) 0.95
Associated features in females with an FMR1 premutation. J Neurodev Disord (2014) 0.94
The role of rare structural variants in the genetics of autism spectrum disorders. Cytogenet Genome Res (2009) 0.93
Molecular pathogenesis of fragile X-associated tremor/ataxia syndrome. J Investig Med (2009) 0.93
FMR1 epigenetic silencing commonly occurs in undifferentiated fragile X-affected embryonic stem cells. Stem Cell Reports (2014) 0.92
Instability of the CGG repeat and expression of the FMR1 protein in a male fragile X patient with a lung tumor. Am J Hum Genet (1995) 0.92
Overlapping submicroscopic deletions in Xq28 in two unrelated boys with developmental disorders: identification of a gene near FRAXE. Am J Hum Genet (1995) 0.92
RAN translation at CGG repeats induces ubiquitin proteasome system impairment in models of fragile X-associated tremor ataxia syndrome. Hum Mol Genet (2015) 0.92
Compact structures of d(CNG)n oligonucleotides in solution and their possible relevance to fragile X and related human genetic diseases. Nucleic Acids Res (1995) 0.91
Anticipation legitimized: unstable DNA to the rescue. Am J Hum Genet (1992) 0.91
Analysis of replication timing at the FRA10B and FRA16B fragile site loci. Chromosome Res (2000) 0.91
Origins of the fragile X syndrome mutation. J Med Genet (1993) 0.91
Genetic analysis of children of atomic bomb survivors. Environ Health Perspect (1996) 0.91
FMR1 CGG-repeat instability in single sperm and lymphocytes of fragile-X premutation males. Am J Hum Genet (1999) 0.91
Interruption of the fragile X syndrome expanded sequence d(CGG)(n) by interspersed d(AGG) trinucleotides diminishes the formation and stability of d(CGG)(n) tetrahelical structures. Nucleic Acids Res (2000) 0.89
Mouse models of the fragile X premutation and fragile X-associated tremor/ataxia syndrome. J Neurodev Disord (2014) 0.89
The Repeat Expansion Diseases: The dark side of DNA repair. DNA Repair (Amst) (2015) 0.88
Hypomethylation of an expanded FMR1 allele is not associated with a global DNA methylation defect. Am J Hum Genet (1999) 0.86
Unusual (CGG)n expansion and recombination in a family with fragile X and DiGeorge syndrome. J Med Genet (1995) 0.86
X inactivation of the FMR1 fragile X mental retardation gene. J Med Genet (1995) 0.84
Molecular and genetic analysis of the Drosophila model of fragile X syndrome. Results Probl Cell Differ (2012) 0.83
DNA methylation and replication: implications for the "deletion hotspot" region of FMR1. Hum Genet (2005) 0.83
Fixed and random effects in the variation of the finger ridge count: a study of fragile-X families. Am J Hum Genet (1992) 0.82
RNA pathogenesis via Toll-like receptor-activated inflammation in expanded repeat neurodegenerative diseases. Front Mol Neurosci (2013) 0.81
General overgrowth in the fragile X syndrome: variability in the phenotypic expression of the FMR1 gene mutation. J Med Genet (1995) 0.80
Simplified strategy for rapid first-line screening of fragile X syndrome: closed-tube triplet-primed PCR and amplicon melt peak analysis. Expert Rev Mol Med (2015) 0.79
A single trinucleotide, 5'AGC3'/5'GCT3', of the triplet-repeat disease genes confers metal ion-induced non-B DNA structure. Nucleic Acids Res (1993) 0.78
Prospects of TAT-mediated protein therapy for fragile X syndrome. J Mol Histol (2004) 0.78
Identification of expanded alleles of the FMR1 Gene in the CHildhood Autism Risks from Genes and Environment (CHARGE) study. J Autism Dev Disord (2013) 0.78
Fragile X Syndrome: Scientific Background and Screening Technologies. J Mol Diagn (2015) 0.77
Investigation of amygdala volume in men with the fragile X premutation. Brain Imaging Behav (2011) 0.77
Anticipation in hereditary disease: the history of a biomedical concept. Hum Genet (2011) 0.77
Sustained expression of FMR1 mRNA from reactivated fragile X syndrome alleles after treatment with small molecules that prevent trimethylation of H3K27. Hum Mol Genet (2016) 0.77
Methotrexate treatment of FraX fibroblasts results in FMR1 transcription but not in detectable FMR1 protein levels. J Neurodev Disord (2013) 0.77
Epigenetics and Triplet-Repeat Neurological Diseases. Front Neurol (2015) 0.76
Group I metabotropic glutamate receptor mediated dynamic immune dysfunction in children with fragile X syndrome. J Neuroinflammation (2014) 0.76
Genetic effects on human cognition: lessons from the study of mental retardation syndromes. J Neurol Neurosurg Psychiatry (2002) 0.76
Fragile X syndrome. Arch Dis Child (1995) 0.76
DNA testing for fragile X syndrome: implications for parents and family. J Med Genet (1997) 0.76
Fragile X syndrome: a pilot proton magnetic resonance spectroscopy study in premutation carriers. J Neurodev Disord (2012) 0.76
c-Jun N-terminal kinase regulates mGluR-dependent expression of post-synaptic FMRP target proteins. J Neurochem (2013) 0.75
Cloning of the gene for the fragile X syndrome: implications for the clinical geneticist. J Med Genet (1991) 0.75
You can build it ... but will they come?: the potential "expansion" of testing methodologies for fragile X syndrome. J Mol Diagn (2009) 0.75
Preservation of duplicate genes by complementary, degenerative mutations. Genetics (1999) 18.29
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature (1995) 13.80
Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell (1991) 12.27
AMINO ACID INCORPORATION INTO PROTEINS BY ESCHERICHIA COLI RIBOSOMES. Proc Natl Acad Sci U S A (1960) 11.02
Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome. Cell (2001) 8.04
Absence of expression of the FMR-1 gene in fragile X syndrome. Cell (1991) 7.04
Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature (1995) 6.62
Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function. Cell (2001) 6.50
Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CCG)n. Science (1991) 5.99
Isolation of single-copy human genes from a library of yeast artificial chromosome clones. Science (1989) 5.29
Febrile seizures and generalized epilepsy associated with a mutation in the Na+-channel beta1 subunit gene SCN1B. Nat Genet (1998) 4.91
Estimate of the genomic mutation rate deleterious to overall fitness in E. coli. Nature (1996) 4.88
FMR1 protein: conserved RNP family domains and selective RNA binding. Science (1993) 4.77
Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med (1994) 4.74
Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome. Nat Genet (1996) 4.62
Rapid isolation of DNA probes within specific chromosome regions by interspersed repetitive sequence polymerase chain reaction. Genomics (1990) 4.34
Structure and organization of ribosomal DNA. Biochimie (1991) 4.31
DNA methylation represses FMR-1 transcription in fragile X syndrome. Hum Mol Genet (1992) 4.22
The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome. Nat Genet (2001) 4.15
Potentiation of rifampicin and 5-fluorocytosine as antifungal antibiotics by amphotericin B (yeast-membrane permeability-ribosomal RNA-eukaryotic cell-synergism). Proc Natl Acad Sci U S A (1972) 4.09
Long-term follow-up results of a randomized drug abuse prevention trial in a white middle-class population. JAMA (1995) 3.98
X-linked anhidrotic (hypohidrotic) ectodermal dysplasia is caused by mutation in a novel transmembrane protein. Nat Genet (1996) 3.90
Competency development in public health leadership. Am J Public Health (2000) 3.84
Mutant GABA(A) receptor gamma2-subunit in childhood absence epilepsy and febrile seizures. Nat Genet (2001) 3.83
Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and premutation carriers. Hum Mol Genet (2001) 3.82
PROTEIN SYNTHESIS IN ERYTHROID CELLS, I. RETICULOCYTE RIBOSOMES ACTIVE IN STIMULATING AMINO ACID INCORPORATION. Proc Natl Acad Sci U S A (1962) 3.81
FMRP associates with polyribosomes as an mRNP, and the I304N mutation of severe fragile X syndrome abolishes this association. Mol Cell (1997) 3.71
The rate of polygenic mutation. Genet Res (1988) 3.58
Comparing mutational variabilities. Genetics (1996) 3.54
Trinucleotide repeat expansion and human disease. Annu Rev Genet (1995) 3.47
The rate of spontaneous mutation for life-history traits in Caenorhabditis elegans. Genetics (1999) 3.44
Biosynthetic precursors of 30S and 50S ribosomal particles in Escherichia coli. Biochemistry (1968) 3.43
Mechanism and regulation of bacterial ribosomal RNA processing. Annu Rev Microbiol (1990) 3.37
Emerin deletion reveals a common X-chromosome inversion mediated by inverted repeats. Nat Genet (1997) 3.30
Polyribosome metabolism in Escherichia coli. I. Extraction of polyribosomes and ribosomal subunits from fragile, growing Escherichia coli. J Mol Biol (1966) 3.29
A mutation in human CMP-sialic acid hydroxylase occurred after the Homo-Pan divergence. Proc Natl Acad Sci U S A (1998) 3.26
The fragile X mental retardation protein inhibits translation via interacting with mRNA. Nucleic Acids Res (2001) 3.18
Incidence and origin of "null" alleles in the (AC)n microsatellite markers. Am J Hum Genet (1993) 3.18
In vitro activity of a new pneumocandin antifungal, L-743,872, against azole-susceptible and -resistant Candida species. Antimicrob Agents Chemother (1997) 3.17
A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nat Genet (1995) 3.15
Impact of face-washing on trachoma in Kongwa, Tanzania. Lancet (1995) 3.06
Fragile X mental retardation protein: nucleocytoplasmic shuttling and association with somatodendritic ribosomes. J Neurosci (1997) 2.93
Medical services in social health maintenance organizations. Gerontologist (1993) 2.81
Preventing adolescent drug abuse through a multimodal cognitive-behavioral approach: results of a 3-year study. J Consult Clin Psychol (1990) 2.81
High direct estimate of the mutation rate in the mitochondrial genome of Caenorhabditis elegans. Science (2000) 2.78
Cryptic and polar variation of the fragile X repeat could result in predisposing normal alleles. Cell (1994) 2.73
Translational suppression by trinucleotide repeat expansion at FMR1. Science (1995) 2.73
CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell (1993) 2.73
Toward an ecological/transactional model of community violence and child maltreatment: consequences for children's development. Psychiatry (1993) 2.73
Nucleolytic processing of ribonucleic acid transcripts in procaryotes. Microbiol Rev (1986) 2.70
Tissue specific expression of FMR-1 provides evidence for a functional role in fragile X syndrome. Nat Genet (1993) 2.69
Comparison of alfentanil with suxamethonium in facilitating nasotracheal intubation in day-case anaesthesia. Br J Anaesth (1993) 2.65
Locations and contexts of sequences that hybridize to poly(dG-dT).(dC-dA) in mammalian ribosomal DNAs and two X-linked genes. Nucleic Acids Res (1988) 2.64
X-linked situs abnormalities result from mutations in ZIC3. Nat Genet (1997) 2.62
Acetylated histones are associated with FMR1 in normal but not fragile X-syndrome cells. Nat Genet (1999) 2.59
Pharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain Society. Pain Res Manag (2007) 2.59
Common chromosomal fragile site FRA16D sequence: identification of the FOR gene spanning FRA16D and homozygous deletions and translocation breakpoints in cancer cells. Hum Mol Genet (2000) 2.56
Physical activity and minority women: a qualitative study. Health Educ Behav (1998) 2.55
PAK3 mutation in nonsyndromic X-linked mental retardation. Nat Genet (1998) 2.52
Binding of adenosine 3':5'-cyclic phosphate to G factor of Escherichia coli, and its effects on GTPase, RNase V, and protein synthesis. Proc Natl Acad Sci U S A (1970) 2.49
A survey of prelicensure pain curricula in health science faculties in Canadian universities. Pain Res Manag (2009) 2.49
The fragile X mental retardation protein is a ribonucleoprotein containing both nuclear localization and nuclear export signals. Hum Mol Genet (1996) 2.49
Hygiene factors and increased risk of trachoma in central Tanzania. Arch Ophthalmol (1989) 2.45
Human Xq24-Xq28: approaches to mapping with yeast artificial chromosomes. Am J Hum Genet (1990) 2.45
Selection of sucrose-dependent Escherichia coli to obtain envelope mutants and fragile cultures. Science (1966) 2.43
Evidence of founder chromosomes in fragile X syndrome. Nat Genet (1992) 2.38
Contributions of Anopheles larval control to malaria suppression in tropical Africa: review of achievements and potential. Med Vet Entomol (2007) 2.37
The fitness effects of spontaneous mutations in Caenorhabditis elegans. Evolution (2000) 2.36
Amphotericin B potentiation of rifampicin as an antifungal agent against the yeast phase of Histoplasma capsulatum. Science (1972) 2.31
Genome-wide association scan for five major dimensions of personality. Mol Psychiatry (2008) 2.29
Pathological consequences of sequence duplications in the human genome. Genome Res (1998) 2.26
Potentiation of the antifungal effects of antibiotics by amphotericin B. Antimicrob Agents Chemother (1972) 2.24
A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome. Am J Hum Genet (1997) 2.22
(Over)correction of FMR1 deficiency with YAC transgenics: behavioral and physical features. Hum Mol Genet (2000) 2.17
Multiple ribosomal RNA cleavage pathways in mammalian cells. Nucleic Acids Res (1981) 2.17
The SH3 domain of amphiphysin binds the proline-rich domain of dynamin at a single site that defines a new SH3 binding consensus sequence. J Biol Chem (1997) 2.16
A refined physical map of the long arm of human chromosome 16. Genomics (1991) 2.15
Synthesis of a large precursor to ribosomal RNA in a mutant of Escherichia coli. Proc Natl Acad Sci U S A (1973) 2.14
Isolation of an FMRP-associated messenger ribonucleoprotein particle and identification of nucleolin and the fragile X-related proteins as components of the complex. Mol Cell Biol (1999) 2.13
The fragile X site in somatic cell hybrids: an approach for molecular cloning of fragile sites. Science (1987) 2.13
Understanding the molecular basis of fragile X syndrome. Hum Mol Genet (2000) 2.13
Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG-CSF): an analysis of factors correlating with the tempo of engraftment after transplantation. Br J Haematol (1994) 2.11
Assignment of anonymous DNA probes to specific intervals of human chromosomes 16 and X. Hum Genet (1989) 2.10
X chromosome map at 75-kb STS resolution, revealing extremes of recombination and GC content. Genome Res (1997) 2.06
Risk factors for constant, severe trachoma among preschool children in Kongwa, Tanzania. Am J Epidemiol (1996) 2.03
Predicate-argument structure as a link between linguistic and nonlinguistic representations. Brain Lang (1990) 2.02
Proteinuria with streptokinase. Lancet (1993) 2.01
Neuronal sodium-channel alpha1-subunit mutations in generalized epilepsy with febrile seizures plus. Am J Hum Genet (2001) 2.01
Isolation and characterisation of (AC)n microsatellite genetic markers from human chromosome 16. Genomics (1992) 2.00
TMS1, a novel proapoptotic caspase recruitment domain protein, is a target of methylation-induced gene silencing in human breast cancers. Cancer Res (2000) 1.98
Failure to confirm association of a polymorphism in ABCB1 with multidrug-resistant epilepsy. Neurology (2004) 1.98
Patterns of genetic architecture for life-history traits and molecular markers in a subdivided species. Evolution (2001) 1.98